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Background:  Airway  smooth  muscle  (ASM)  is  con-
sidered to be a target for mediators released during
airway inflammation.
Aims: To  investigate  the expression of c-fos, a  con-
stituent of the transcription factor activator protein-1,
in  human  ASM  cells.  In  addition,  to  measure  the
release  of  interleukin  (IL)-6  into  the  conditioned
medium  of  stimulated  ASM  cells,  as  well  as  DNA
biosynthesis and changes in cell number.
Methods:  Serum-deprived  human  ASM  cells  in  the
G0/G1 phase were stimulated with the pro-inflamma-
tory  cytokines; tumour necrosis factor-a , IL-1b , IL-5
and  IL-6.  The  expression  of  mRNA  encoding  the
proto-oncogene c-fos was measured by Northern blot
analysis.  Cell  proliferation  was  assessed  by
{3H}-thymidine incorporation  assays and cell  count-
ing, and IL-6 levels in cell-conditioned medium were
measured by enzyme-linked immunosorbent assay.
Results: All  of  the  cytokines  investigated  induced a
rapid  (within  1h)  and  transient  increase  in  the
expression of mRNA encoding c-fos, followed by the
expression  and  enhanced  release  of  IL-6.  Cell  pro-
liferation  remained  unchanged  in  cytokine-stimu-
lated cells.
Conclusions:  Cytokine-induced  c-fos  expression  in
human ASM cells could be described as a marker of
cell  Ôactivation’.  The  possible  association  of  these
results with airway inflammation, through secondary
intracellular  mechanisms  such  as  cytokine  produc-
tion, is discussed.
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Introduction
Asthma is  a  chronic  disease of  the  airways  charac-
terised  by  reversible  airway  obstruction,  airway
hyper-responsiveness and airway wall inflammation.
Important pathological features of asthmatic airways
include inflammatory cell infiltration, epithelial shed-
ding, basement membrane thickening and increased
mass  of airway  smooth muscle  (ASM).  Both  hyper-
plasia (an increase in cell number) and hypertrophy
(an increase in cell size) of ASM cells contribute to
the increased smooth muscle content of the airway
wall.1–3 The release of mediators from the infiltrating
inflammatory cells has been proposed to contribute
to changes in airway structure. The resulting changes
form  the  basis  for  airway  wall  remodelling,  a  phe-
nomenon  believed to have profound consequences
on  airway  function.  Human  ASM  cells  in  culture
provide  a  useful  model  for  investigating  physio-
logical  responses,  and  studies  of  human  ASM  cell
responses to mediators of asthma are important for
understanding  the  mechanisms  involved  in  airway
inflammation and remodelling.
Bronchoalveolar  lavage  fluid  and  serum  from
symptomatic  asthma  patients  contains  significantly
increased  levels  of  pro-inflammatory  cytokines,
growth  factors  and  other  inflammatory  mediators,
suggesting  that  these  mediators  may  also  be  in
the  vicinity  of  the  airway  mucosa.4–11 Moreover,
pro-inflammatory  cytokines  such  as  tumour  necro-
sis  factor-a (TNF-a ),  interleukin  (IL)-1b and  IL-6
have  been  reported  to  stimulate  DNA  synthesis
in  cultured  ASM  cells  derived  from  different
species.12–14 IL-6  has  pro-inflammatory  effects  that
may  be  relevant  to  airway  wall  inflammation,
including  mucus  hypersecretion,  the  terminal
differentiation  of  B  cells  into  antibody  producing
cells, upregulation  of  IL-4-dependent immunoglobu-
lin  (Ig)E  production,  and  differentiation  of
immature  mast  cells.15–18 Possible  anti-inflamma-
tory  properties  of  IL-6  include  the  inhibition  of
macrophage  cytokine  production,  stimulation
of  the  production  of  anti-inflammatory  molecules
such  as  IL-1  receptor  antagonist  and  soluble
TNF  receptor  p55,  and  reduced  airway
responsiveness.19–24
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the leucine zipper family and it heterodimerises with
c-jun  to  constitute  the  AP-1  transcription  factor.25
Induction of c-fos, and subsequent cell proliferation
and/or differentiation, has previously suggested that
c-fos  can  be  considered a  proliferation  marker.25,26
The purpose of the present study was to investigate
the effects of a range of cytokines (TNF-a , IL-1b , IL-5
and IL-6) on the expression of the immediate early
response  gene,  c-fos,  as  well  as  the  release of  the
pleiotropic cytokine IL-6 in cultured human ASM cells.
Our  results  demonstrate  that  all  of  the  cytokines
investigated induced a rapid and transient expression
of mRNA encoding c-fos. Moreover, they induced the
release of IL-6 protein into the conditioned medium.
However,  none  of  the  cytokines  stimulated  DNA
biosynthesis  or ASM  cell  mitogenesis. These results
suggest that it may be preferable to describe c-fos as a
marker of ‘activation’ in ASM cells  – leading to the




The following solutions and reagents were obtained
from Life Technologies BV (Breda, The Netherlands):
sodium pyruvate, non-essential amino acid mixture,
gentamicin, penicillin/streptomycin, amphotericin B,
Dulbecco’s  modified  Eagle’s  medium  (DMEM),  and
0.5% trypsin/0.02% ethylenediamine tetraacetic acid
(EDTA). Insulin, transferrin and ascorbate, IL-1b and
IL-5 were purchased from Sigma BV (Zwijndrecht, The
Netherlands). We procured foetal bovine serum (FBS)
from  Bio-Whitaker  BV  (Verviers,  Belgium),  TNF-a
from  Knoll AG  (Ludwigshaven,  Germany),  methyl-
[3H]-thymidine  from  Amersham  Nederland  BV
(‘s-Hertogenbosch,  The  Netherlands)  and  recombi-
nant human IL-6 from Promega (Leiden, The Nether-
lands). Human specific antibodies for the IL-6 enzyme-
linked  immunosorbent  assay  (ELISA  assay)  were
procured from Medgenix (Breda, The Netherlands).
Human ASM cell culture
Human bronchial smooth muscle cells were isolated
as described previously.27,28 Briefly, bronchial smooth
muscle  was dissected from  a fresh macroscopically
normal lobar or main bronchus obtained immediately
following  surgery  of  patients with  lung  carcinoma.
The  medical  ethical  and  research  committee  of
Erasmus  University  Medical  Center  approved  this
study (MEC 150.321/1996/45). After removal of the
epithelium, pieces of smooth muscle were dissected
free of adherent connective and parenchymal tissue
under aseptic conditions. Smooth muscle fragments
were  incubated  in  HBSS  containing  bovine  serum
albumin (fraction V, 10mg/ml), collagenase (type XI,
1mg/ml) and elastase (type IV, 3.3U/ml) at 37°C in a
humidified incubator (ASSAB, model T154; Clean Air
Techniek BV, Woerden, The Netherlands) containing
5%  CO2 in  air.  After  enzymatic  digestion,  the  cell
suspension  was  centrifuged  and  the  pellet  was
washed in DMEM containing 10% (v/v) FBS supple-
mented with sodium pyruvate (1 mM), non-essential
amino acid mixture (1:100),  gentamicin (45 m g/ml),
penicillin (100U/ml), streptomycin (100 m g/ml) and
amphotericin B (1.5 m g/ml). Cells were subsequently
seeded in a 35mm dish and maintained in culture by
replacing the medium every 72h. After 10–14 days in
culture, ASM cells grew to confluence and were then
removed from the plastic base of each dish using 0.5%
trypsin/0.02%  EDTA,  and  sub-cultured  into  25cm2
tissue culture flasks. At confluence, cells were further
passaged  using  trypsin/EDTA  solution  into  75cm2
tissue culture flasks. Confluent cells in the fourth to
sixth passages were used for experiments.
Stimulation of human ASM cells
The  ASM  cell  growth  was  synchronised  prior  to
treatment by  washing the cell  monolayers twice in
phosphate-buffered  saline  (PBS)  (140 mM  NaCl,
2.6 mM  KCl,  1.4 mM  KH2PO4,  8.1 mM  Na2H-
PO4·2H2O; pH 7.4) and then replacing the medium
with  serum-free  DMEM  supplemented  with  1 m M
insulin, 5 m g/ml transferrin and 100 m M ascorbate for
72h. Using flow cytometric analysis of human ASM
cells, we have found that 72h of serum deprivation
resulted in approximately 85–90% of the cells remain-
ing in the G0/G1 phase. Growth-arrested cell mono-
layers were treated with either TNF-a (10ng/ml), IL-
1b (0.5ng/ml), IL-5 (2ng/ml) or IL-6 (5ng/ml) in fresh
FBS-free  DMEM  in  a  time-dependent  manner.  Cell-
conditioned  medium  was  collected  and  stored  at
–20°C until assayed for IL-6 levels by ELISA. Stimula-
tion of human ASM cells with cytokines can induce
the release of prostaglandins, which may then inhibit
the  proliferation of ASM  cells.29 Therefore, we  also
examined the effects of the aforementioned cytokines
on human ASM cell proliferation in the presence of
indomethacin (1 m M), which is a non-specific cyclo-
oxygenase inhibitor.
Isolation of total cellular RNA and Northern
blot analysis
Treated and untreated human ASM cells were washed
in PBS and directly lysed in guanidinium thiocyanate
buffer. The  lysate was  repeatedly passed through  a
23-gauge  needle  to  shear  the  genomic  DNA. Total
cellular  RNA  was  isolated  using  the  method  as
described earlier.27 The RNA concentration was esti-
mated by optical density measurements and a DNA/
protein ratio of ‡ 1.8 was accepted. Samples of total
S. McKay et al.
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hyde-containing loading buffer and size fractionated
on a 1% agarose gel containing 2.2M formaldehyde.
Ethidium  bromide  stained  gels  were  photographed
and RNA was transferred onto hybond-N membrane
(Amersham Nederland BV) by the alkaline downward
capillary transfer method also described previously.27
The filters were air-dried and ultraviolet cross-linked
in a gene linker (Biorad Laboratories B.V., Veenendaal,
The  Netherlands). Blots  were  hybridised  with  radi-
olabelled mouse c-fos (2.1kb fragment) or a reference
house  keeping  gene,  glyceraldehyde-3-phosphate
dehydrogenase  (GAPDH)  cDNA  probes  (American
Type  Culture  Collection,  Rockville,  MD,  USA).27
Hybridisation  signals  were  quantified  by  scanning
laser densitometry using the Ultroscan XL enhanced
laser densitometer (LKB, Bromma, Sweden). Signals
were  normalised  with  respect  to  GAPDH  mRNA
values  and  expressed  as  relative  optical  density  in
stimulated cells versus controls.
Measurement of IL-6 protein levels by ELISA
IL-6 protein levels in ASM cell-conditioned medium,
after  24h  of  stimulation,  were  determined using  a
solid-phase sandwich ELISA as described previously.28
The  increase  in  IL-6  secretion  was  expressed  as
nanograms per millilitre, and data are shown as the
fold increase in IL-6 secretion relative to controls. The
detection limit of the IL-6 ELISA method was 50pg of
IL-6/ml. No correction for cell number variation was
made because the cells were serum deprived 16–24h




Effects of the different cytokines on DNA biosynthesis
was  evaluated  by  incorporation  of  methyl-
[3H]-thymidine.  Cells  were  transferred  into  24-well
plates at a seeding density of 3 ´ 104 cells/well. After
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FIG. 1. Representative Northern blots of c-fos expression in human airway smooth muscle (ASM) cells treated with: (A) IL-1b
(0.5ng/ml), (B) IL-5 (2ng/ml), (C) IL-6 (5ng/ml), or (D) TNF-a (10ng/ml). Total RNA from control C (cultured in serum-free DMEM)
and treated cells was subjected to Northern hybridisation with a radiolabelled c-fos cDNA probe. Rehybridisation of each filter
with a GAPDH cDNA probe was performed for reference purposes. These Northern blots are representative of blots from three
independent experiments.24h  in  culture,  the  sub-confluent  cell  monolayers
were growth arrested as already described. Cells were
incubated with methyl-[3H]-thymidine (1 m Ci/well) in
either fresh FBS-free DMEM (control), DMEM contain-
ing the various cytokines, or 10% serum for 1, 2, 3, 4
or 5 days. After stimulation, the cells were washed in
PBS, fixed with ice-cold methanol and exposed to ice-
cold trichloroacetic acid (5% w/v). The acid-insoluble
fraction was lysed in 0.3M NaOH and the incorpo-
rated radioactivity was determined in a liquid-scintilla-
tion counter (Packard 1500 Tri-carb liquid scintillation
analyser; Packard-Becker BV, Delft, The Netherlands).
The  data  are  expressed  as  the  fold  increase  in
thymidine incorporation relative to controls.
Cell counting
To assess changes in cell number in relation to pro-
inflammatory  cytokines,  we  also  performed  direct
cell  counting.  Cells were incubated with the afore-
mentioned stimuli for 7 days. Following stimulation,
the cell-conditioned medium  was removed and the
cells were washed twice in PBS and then detached in
50 m l  of  trypsin/EDTA  by  incubating  at  room  tem-
perature for 10min. We then added 50 m l PBS to each
well and the cells were dispersed by gentle pipetting.
The resulting cell suspension was added to 10ml of
isotonic counting solution (sodium chloride, 6.38g/l;
sodium tetraborate, 0.2g/l; boric acid, 1.0g/l; EDTA
0.2g/l)  and  the  cells  were  counted  in  a  CASY-1
Coulter  counter  (Sch¨ arfe  system,  Reutlingen,
Germany).
Statistical analysis
All  data in  the  figures  and  tables  are  presented as
mean ± SEM. Statistical analysis was performed using
a two-tailed, independent sample t-test. Significance
was accepted at p < 0.05.
Results
Expression of the c-fos proto-oncogene
Expression  of  the  proto-oncogene c-fos,  a  member
of  the  leucine  zipper  family,  was  examined  in
cultured  human  ASM  cells  treated  with  different
cytokines.  Representative  Northern  blots  showing
the  expression  pattern of  c-fos  in  relation  to  IL-1b
(0.5ng/ml),  IL-5  (2ng/ml),  IL-6  (5ng/ml)  or TNF-a
(10ng/ml) are shown in Figure 1. IL-1b and IL-5, IL-
6  and  TNF-a induced  the  expression  of  mRNA
encoding c-fos in cultured human ASM cells as early
as  30min,  and  the  expression  levels  reached  a
maximum  between  45  and  60min.  Rapidly  and
transiently  induced  mRNA  levels  declined  abruptly
to  non-detectable  levels  at  120min,  except  in  the
case  of  IL-5  where  c-fos  mRNA  levels  remained
elevated  up  to  120min  (Fig.  1B). To  compare  the
expression  pattern  and  to  verify  the  integrity  of
total  RNA  samples,  GAPDH,  a  housekeeping  gene
was  used  to  re-hybridise  the  membranes. A  strong
dark  band  at  1.4kb  was  expressed  in  each  RNA
preparation (Fig. 1 A–D).
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FIG.  2.  Production  and  release  of  IL-6  by  human  airway  smooth  muscle  (ASM)  cells.  Growth-arrested  ASM  cells  were
stimulated in the absence (control) or presence of different cytokines for 24h. Data represent the mean ± SEM of triplicate
values from three or four independent experiments using conditioned medium from ASM cells cultured from different patients.
Data are expressed as the fold increase in IL-6 secretion compared with respective controls.Release of IL-6 protein into the conditioned
medium
The concentration of IL-6 in the conditioned medium
of  cultured  human  ASM  cells  following  24h  of
stimulation  with  IL-1b ,  IL-5  and TNF-a was  6.56  ±
0.78, 1.10 ± 0.08 and 3.17 ± 0.64ng/ml, respectively.
Conditioned  medium  derived  from  controls  cells
showed only a negligible amount (0.14 ± 0.02ng/ml)
of  IL-6. The  fold  increase  in  IL-6  concentration  in
relation to different cytokines after normalising with
their respective controls is shown in Figure 2. IL-1b
was  the  most  potent  cytokine  for  cultured  human
ASM cells in producing IL-6 protein, where the levels
rose  over  30-fold  as  compared with  the  respective
control (Fig. 2). To verify that the measured amounts
of IL-6 in the conditioned medium were due to the
release of de novo synthesised IL-6, we also assessed
the  concentration  of  IL-6  in  the  cell  lysates  of
unstimulated human ASM cells. These IL-6 levels were
found to be negligible (0.10 ± 0.01ng/ml).
[
3H]-Thymidine incorporation
Figure 3 shows the DNA biosynthesis data assessed by
[3H]-thymidine  incorporation  into  DNA  during  a
period of 5 days. We found that 10% FBS increased
thymidine incorporation up to 10-fold as compared
with  cells  cultured  in  medium  deprived  of  FBS
(controls). Surprisingly, none of the cytokines studied
here  could  result  in  the  induction  of  DNA biosyn-
thesis  measured  by  [3H]-thymidine  incorporation
assay in this cultured human ASM cell model. Even in
the presence of the cyclo-oxygenase inhibitor indom-
ethacin, the aforementioned cytokines failed to elicit
a proliferative response in cultured human ASM cells
even up to 3 days of stimulation (Table 1).
Cell counting
Cell counts did not change after 7 days of incubation
of serum-deprived human ASM cells with the different
cytokines (TNF-a , IL-1b , IL-5 and IL-6) at the concen-
trations  mentioned  earlier.  The  cell  counts  data
depicted  in  Table  2  once  again  verify  the  non-
mitogenic response of the cytokines studied here, and
this  data  is  in  agreement  with  the  [3H]-thymidine
incorporation results.
Discussion
The purpose of the present study was to investigate
the  relative  contributions  of  a  number  of  pro-
inflammatory  cytokines,  on  responses  of  cultured
Pro-inflammatory cytokines and airway smooth smooth muscle
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FIG. 3. Thymidine incorporation measured after 5 days in semi-confluent, growth arrested, human airway smooth muscle
(ASM)  cells  stimulated  with  10%  serum  (circles),  10ng/ml  TNF-a (triangles),  0.5ng/ml  IL-1b (squares)  or  2ng/ml  IL-5
(diamonds). Values are calculated from three or four independent experiments of four determinations each, and expressed as
the fold increase in thymidine incorporation relative to controls. FBS, foetal bovine serum.human ASM cells, by evaluating their individual ability
to  induce  the  expression  of  the  immediate  early
response  gene  c-fos,  as  well  as  the  release  of  the
pleiotropic cytokine IL-6. Also, the ability of the pro-
inflammatory  cytokines to  induce  cell  mitogenesis,
under  identical  experimental  conditions,  was  eval-
uated.  Our  results  demonstrate  that  a  rapid  and
transient  expression  of  mRNA  encoding  c-fos  was
induced by all of the cytokines investigated. However,
none of the cytokines induced DNA biosynthesis or
an increase in cell numbers in this human ASM cell
model.  Moreover,  all  of  the  cytokines  investigated
induced  the  release  of  de  novo synthesised  IL-6
protein into the cell-conditioned medium.
The rapid and transient induction of the immedi-
ate  early  response  gene  c-fos,  and  subsequent  cell
proliferation  and/or  differentiation,  has  previously
suggested  that  c-fos  can  be  considered a  prolifera-
tion  marker in ASM  cells.16,30 However,  it  has  also
been  shown  that  c-fos  induction  alone  is  insuffi-
cient  for  cell  proliferation  in  a  number  of  cells  of
mesenchymal  origin.31,32 Histamine  and  ET-1  have
previously  been  shown  to  increase  levels  of  c-fos
mRNA, peaking at 30min  of  stimulation,  in  canine
and ovine ASM cells, respectively.16,30 Both of these
studies  associated  c-fos  expression  with  ASM  cell
mitogenesis.  However,  we  could  not  demonstrate
that c-fos expression was directly associated with a
proliferative  response  in  our  human  ASM  cell
model. These findings are also supported by one of
our previous studies, where we showed that angio-
tensin  II  induced  the  expression  of  c-fos  without
subsequent cell proliferation.27
Stimulation of human ASM cells with either TNF-a
(10ng/ml)  or  IL-1b (0.5ng/ml),  in  serum-free
medium, induced the expression of c-fos but did not
result  in  an increase in  thymidine incorporation or
cell counts in our study. Although work from other
groups has previously shown a mitogenic response, it
is important to emphasise that the culture media, TNF-
a (10ng/ml) in the study from Amrani et al.14 and IL-
1b (0.1ng/ml) in the study from De et al.,13 contained
serum.12–14 TNF-a , IL-1b and growth factors (present
in  serum)  can  activate  mitogen-activated  protein
(MAP)  kinases  in  smooth  muscle  cells.33–35 MAP
kinases are key transducers of extracellular signals in
pathways  leading  to  cell  proliferation  and  differ-
entiation. Signals activated by TNF-a or IL-1b together
with serum may synergistically induce proliferation,
possibly  explaining  the  previously  reported  pro-
liferative response. Stewart et al. found an increase in
thymidine  incorporation  using  TNF-a at  very  low
concentrations  (5.0pg/ml  to  0.5ng/ml)  in  human
ASM cells, but at higher concentrations (5.0ng/ml)
this effect was abolished.12 De et al. also found that IL-
1 in the absence of indomethacin inhibited prolifera-
tion of ASM cells.13 We did not observe proliferative
effects in either the absence or in  the presence of
indomethacin, again suggesting that considerably low
concentrations of serum-derived factors may synergis-
tically contribute to ASM cell mitogenesis.
The  upregulation  of  c-fos  expression,  in  human
ASM cells, by the pro-inflammatory cytokines investi-
gated  in  our  study,  was  thus  insufficient  for  the
induction  of  cell  proliferation.  Radiolabelled  thymi-
dine incorporation demonstrated that serum-induced
DNA biosynthesis in cultured human ASM cells, which
is a well-established phenomenon in ASM cell culture.
IL-5 stimulation of human ASM cell proliferation has
not  previously  been  reported,  although  ASM  cells
have been  reported to  express  and  secrete IL-5  in
response to the serum obtained from allergic asthma
patients.36 We  found  that  IL-5  (2ng/ml)  is  not
mitogenic for human ASM cells, even in the presence
of indomethacin.
The c-fos protein, which is able to translocate to
the nucleus and bind to c-jun, forms a heterodimeric
complex  known  as  activator  protein-1  (AP-1). This
transcription factor can activate gene transcription by
S. McKay et al.
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Table 1. [
3H]-Thymidine incorporation into DNA, measured after 3 days in semi-confluent, growth-arrested human airway
smooth muscle cells stimulated with TNF-a (10ng/ml), IL-1b (0.5ng/ml), IL-5 (2ng/ml) and IL-6 (5ng/ml) in the presence or
absence (control) of 1m M indomethacin
Treatment TNF-a IL-1b IL-5 IL-6
– 1m M indomethacin 1.0 ± 0.11 1.0 ± 0.11 1.0 ± 0.11 1.08 ± 0.16
+ 1m M indomethacin 0.88 ± 0.12 1.08 ± 0.20 0.97 ± 0.20 0.88 ± 0.12
Values are calculated  from one to  three independent  experiments  of four determinations  each, and are expressed as the fold increase in
thymidine incorporation relative to controls ± SEM. Baseline thymidine incorporation at 72h of stimulation was 5500 ± 1000 disintegration per
minute (dpm)/well.
Table 2. Human airway smooth muscle cell numbers after 7
days of stimulation with different cytokines
Treatment Cell number
(fold increase relative to control)
TNF-a 0.97 ± 0.10
IL-1b 0.77 ± 0.12
IL-5 1.30 ± 0.39
IL-6 1.06 ± 0.13
Values are calculated from three or four independent experiments of
four determinations each, and are expressed as the fold increase in
cell number relative to controls ± SEM.binding  to the AP-1 site  in  the  promoter region of
target genes. Several recent studies have shown that
ASM  cell  stimulation  by  cytokines  leads  to  the
expression  and  subsequent  release of  a number  of
inflammatory cytokines and chemokines.28,37–42 The
majority of these pro-inflammatory cytokines contain
AP-1  binding  sites  in  the  promoter  region  of  their
genes. We have recently shown that c-fos induction
precedes IL-6 protein secretion by human ASM cells.28
The transient upregulation of c-fos that we measured
in  this  study  may  contribute  to  the  induction  and
release of cytokines, such as IL-6, thereby playing a
role in the regulation of inflammatory responses in
asthmatic  airways.  IL-6  is  upregulated  in  the  bron-
choalveolar  lavage  fluid  from  symptomatic  asthma
patients and has pro-inflammatory effects that may be
relevant to airway wall inflammation. These include
mucus hypersecretion, the terminal differentiation of
B cells into antibody producing cells, upregulation of
IL-4-dependent IgE production, and differentiation of
immature mast cells.15–18
The present study suggests that ASM cells may play
a  role  in  the  regulation  of  airway  inflammation
through the production of cytokines, like IL-6. This
may occur via upregulation of different genes, includ-
ing cytokines and chemokines such as TGF-b 1, IL-8,
granulocyte macrophage-colony stimulating factor or
RANTES.27,28,37–39 Although the individual cytokines
investigated in our study did not induce human ASM
cell  proliferation,  we  cannot  exclude  that  their
concerted actions in asthmatic airways may contrib-
ute to ASM remodelling. Evidence for the importance
of  combinations  of  mediators  has  recently  been
published.43 Whether the endogenous generation of
cytokines by ASM cells, and especially the release of
IL-6, contributes to the pathogenesis of airway inflam-
mation and remodelling is unclear, but the capacity of
ASM cells to produce IL-6 suggests  that these cells
could participate in local inflammatory events in the
airways.
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